SBTX vs. OPTI, ONC, OBI, NSCI, DEST, HEMO, SNG, IMM, OBD, and BVX
Should you be buying SkinBioTherapeutics stock or one of its competitors? The main competitors of SkinBioTherapeutics include OptiBiotix Health (OPTI), Oncimmune (ONC), Ondine Biomedical (OBI), NetScientific (NSCI), Destiny Pharma (DEST), Hemogenyx Pharmaceuticals (HEMO), Synairgen (SNG), ImmuPharma (IMM), Oxford BioDynamics (OBD), and BiVictriX Therapeutics (BVX). These companies are all part of the "biotechnology" industry.
SkinBioTherapeutics (LON:SBTX) and OptiBiotix Health (LON:OPTI) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, analyst recommendations, dividends, community ranking, profitability, media sentiment, earnings, risk and valuation.
SkinBioTherapeutics has a beta of 1.67, indicating that its share price is 67% more volatile than the S&P 500. Comparatively, OptiBiotix Health has a beta of 1.58, indicating that its share price is 58% more volatile than the S&P 500.
OptiBiotix Health received 98 more outperform votes than SkinBioTherapeutics when rated by MarketBeat users. However, 60.26% of users gave SkinBioTherapeutics an outperform vote while only 59.18% of users gave OptiBiotix Health an outperform vote.
18.8% of SkinBioTherapeutics shares are held by institutional investors. Comparatively, 5.9% of OptiBiotix Health shares are held by institutional investors. 19.8% of SkinBioTherapeutics shares are held by company insiders. Comparatively, 12.5% of OptiBiotix Health shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.
OptiBiotix Health's return on equity of -85.52% beat SkinBioTherapeutics' return on equity.
SkinBioTherapeutics has higher earnings, but lower revenue than OptiBiotix Health. SkinBioTherapeutics is trading at a lower price-to-earnings ratio than OptiBiotix Health, indicating that it is currently the more affordable of the two stocks.
In the previous week, OptiBiotix Health's average media sentiment score of 0.76 beat SkinBioTherapeutics' score of 0.00 indicating that OptiBiotix Health is being referred to more favorably in the news media.
Summary
SkinBioTherapeutics beats OptiBiotix Health on 7 of the 13 factors compared between the two stocks.
Get SkinBioTherapeutics News Delivered to You Automatically
Sign up to receive the latest news and ratings for SBTX and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
SkinBioTherapeutics Competitors List
Related Companies and Tools
